Wondfo Biotech (300482)
SZSE · 300482
Market Cap$7.5B
Revenue$1.9B
Employees2443
Listed OnSZSE
Ticker300482
CEO / ExecMr. Zhongxiong Peng
HeadquartersGuangzhou
MarketMainland China
Websitewww.wondfo.com.cn
Overview
Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rheumatoid arthritis, sex hormone, anemia, gastroenterology, hypertension, thrombus, tumor, inflammation
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.